Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1494 | 2020 |
Digital health is a cultural transformation of traditional healthcare B Meskó, Z Drobni, É Bényei, B Gergely, Z Győrffy Mhealth 3, 2017 | 527 | 2017 |
Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque ZD Drobni, RM Alvi, J Taron, A Zafar, SP Murphy, PK Rambarat, ... Circulation 142 (24), 2299-2311, 2020 | 337 | 2020 |
Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T) RM Alvi, MJ Frigault, MG Fradley, MD Jain, SS Mahmood, M Awadalla, ... Journal of the American College of Cardiology 74 (25), 3099-3108, 2019 | 275 | 2019 |
Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries AG Dastidar, A Baritussio, E De Garate, Z Drobni, G Biglino, P Singhal, ... JACC: Cardiovascular Imaging 12 (10), 1973-1982, 2019 | 207 | 2019 |
CT or invasive coronary angiography in stable chest pain P Maurovich-Horvat, M Bosserdt, KF Kofoed, N Rieckmann, T Benedek, ... New England Journal of Medicine 386 (17), 1591-1602, 2022 | 175 | 2022 |
Myocardial T1 and T2 mapping by magnetic resonance in patients with immune checkpoint inhibitor–associated myocarditis P Thavendiranathan, L Zhang, A Zafar, ZD Drobni, SS Mahmood, ... Journal of the American College of Cardiology 77 (12), 1503-1516, 2021 | 127 | 2021 |
Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines CA Gongora, ZD Drobni, T Quinaglia Araujo Costa Silva, A Zafar, J Gong, ... Heart Failure 10 (8), 559-567, 2022 | 54 | 2022 |
Immune checkpoint inhibitors for cancer and venous thromboembolic events J Gong, ZD Drobni, RM Alvi, SP Murphy, RJ Sullivan, SE Hartmann, ... European Journal of Cancer 158, 99-110, 2021 | 51 | 2021 |
Atorvastatin for anthracycline-associated cardiac dysfunction: the STOP-CA randomized clinical trial TG Neilan, T Quinaglia, T Onoue, SS Mahmood, ZD Drobni, HK Gilman, ... Jama 330 (6), 528-536, 2023 | 48 | 2023 |
Pericardial disease in patients treated with immune checkpoint inhibitors J Gong, ZD Drobni, A Zafar, T Quinaglia, S Hartmann, HK Gilman, ... Journal for immunotherapy of cancer 9 (6), 2021 | 47 | 2021 |
Decreased absolute lymphocyte count and increased neutrophil/lymphocyte ratio with immune checkpoint inhibitor–associated myocarditis ZD Drobni, A Zafar, L Zubiri, DA Zlotoff, RM Alvi, C Lee, S Hartmann, ... Journal of the American Heart Association 9 (23), e018306, 2020 | 47 | 2020 |
The incidence, risk factors, and outcomes with 5-fluorouracil–associated coronary vasospasm A Zafar, ZD Drobni, R Mosarla, RM Alvi, M Lei, UY Lou, VK Raghu, ... Cardio Oncology 3 (1), 101-109, 2021 | 44 | 2021 |
Left ventricular and atrial strain imaging with cardiac computed tomography: validation against echocardiography B Szilveszter, AI Nagy, B Vattay, A Apor, M Kolossváry, A Bartykowszki, ... Journal of Cardiovascular Computed Tomography 14 (4), 363-369, 2020 | 35 | 2020 |
Effect of image reconstruction algorithms on volumetric and radiomic parameters of coronary plaques M Kolossváry, B Szilveszter, J Karády, ZD Drobni, B Merkely, ... Journal of cardiovascular computed tomography 13 (6), 325-330, 2019 | 34 | 2019 |
CT or invasive coronary angiography in stable chest pain DISCHARGE Trial Group New England Journal of Medicine 386 (17), 1591-1602, 2022 | 29 | 2022 |
Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors ZD Drobni, O Michielin, T Quinaglia, DA Zlotoff, L Zubiri, HK Gilman, ... European Journal of Cancer 163, 108-118, 2022 | 27 | 2022 |
The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients S Street, D Chute, I Strohbehn, S Zhao, M Rengarajan, A Faje, ... Annals of Oncology 32 (8), 1050-1051, 2021 | 26 | 2021 |
Heritability of coronary artery disease: insights from a classical twin study ZD Drobni, M Kolossvary, J Karady, AL Jermendy, AD Tarnoki, DL Tarnoki, ... Circulation: Cardiovascular Imaging 15 (3), e013348, 2022 | 25 | 2022 |
Incidence and predictors of CKD and estimated GFR decline in patients receiving immune checkpoint inhibitors DF Chute, S Zhao, IA Strohbehn, N Rusibamayila, H Seethapathy, M Lee, ... American Journal of Kidney Diseases 79 (1), 134-137, 2022 | 25 | 2022 |